Prevention

Eagle Pharmaceuticals randomized its first patient in the Phase 2 study of CAL02, a safe and promising anti-toxin drug that treats severe community-acquired bacterial pneumonia without contributing to antibiotic resistance.

Take 5 minutes to catch up on Infection Control Today®’s highlights for the week ending Aug 20, 2023.

What is a COVID-19 infection? With the definition not consistent, the answer is far from simple.

As children get ready to return to school, pediatric health care providers may start seeing more of this condition in their offices. Here is what you should know.

Are white coats a symbol of medical expertise or a source of potential contamination?

In this Hot Topics in IPC, Saskia v. Popescu, PhD, MPH, MA, CIC, gives the latest on COVID-19, tuberculosis, and changes in leadership at the CDC and NIAID.

Bug of the Month helps educate readers about existing and emerging pathogens of clinical importance in health care facilities today.

Deliver compassionate and empathetic patient-centered care

Connecting and networking with colleagues, finding the right resources, and joining key organizations can help you become a better infection preventionist.

When constructing a health care facility of any size, it is crucial to seek the advice and expertise of an infection preventionist. This article provides guidance on how to do so effectively.

In this installment of IPC Pros Helping Each Other, a long-term care infection preventionists in New Hampshire describes the IPC educational fair her facility organized for the rest of the staff. Michele M, director of nursing services, said, “[The educational fair] was a creative and interactive way to engage staff in infection control education.”

The report has brought to attention the increasing danger of bacteria that are resistant to modern medicine. This problem has already reached alarming levels in many areas of the world.

With malaria making headlines, infection prevention specialists and other IPC professionals seek answers. To provide clarity, ICT® has consulted with 2 experts in the field.

Take 5 minutes to catch up on Infection Control Today®’s highlights for the week ending July 30, 2023.

Choosing the correct disinfectant can be difficult. This expert explains how to select the proper one.

A new remote sexual health testing provider is available to US public health officials. It aims to reduce the increasing spread of sexually transmitted infections.

"If we want to influence our health care workers toward a shift in practice, we must first tackle the core beliefs that drive that behavior," writes Heather Saunders, MPH, RN, CIC.

Sepsis often first appears in the emergency department, making diagnosis challenging and leading to delays. This study examines a new, recently FDA-approved test on how to diagnose earlier.

In this opinion article, the authors discuss their concerns about the recent HICPAC/CDC proposals on infectious diseases.

Mold, a menacing presence that can grow within the walls of your facility, may be lurking and waiting to cause problems. Are you equipped to deal with it?

3D-Printed PPE in emergencies seemed like a great idea during the COVID-19 pandemic. But a recent study shows they could be a contamination risk to patients and staff.

Bug of the Month helps educate readers about existing and emerging pathogens of clinical importance in health care facilities today.

Giantmicrobes is a company that creates fun health and science products that resemble microbes, organs, vaccines, and more and are used for teaching and enjoying.

Neal Buchalter, MBA, president of Parker Laboratories, spoke with Infection Control Today® in an exclusive interview about the product, the companies involved, and how it came to the US market.

Diseases transmitted by mosquitoes are not new to the US, but with malaria in Florida and Texas showing up, protecting against getting bit is even more vital.

AstraZeneca's new drug, a monoclonal antibody, was given FDA approval after the Antimicrobial Drugs Advisory Committee (AMDAC) to the FDA voted in June to recommend the approval of nirsevimab (Beyfortus) for the prevention of respiratory syncytial virus (RSV) disease in infants.

As an oversight agency for the Department of Health and Human Services, the Office of Inspector General is responsible for ensuring the safety and effectiveness of Medicare and Medicaid programs, with a huge priority being patient care. These toolkits provide additional guidance on how to avoid patient injury.

A relatively new threat, the Candida auris fungus has become a dangerous agent due to its ability to form biofilms, which help it survive and spread infections within the environment.

Dengue Fever and Betacoronavirus infections are widespread and dangerous. The cofounder and CEO of Emergex answers questions about them and upcoming Phase II and Phase III studies.

Have foodborne infections returned to prepandemic levels? What information should infection prevention and control personnel offer to patients and staff to prevent an E coli infection?